Quality of Life of Patients with Type 1 Diabetes Mellitus Using Insulin Analog Glargine Compared with NPH Insulin: A Systematic Review and Policy Implications

Author:

Almeida Paulo H. R. F.,Silva Thales B. C.,de Assis Acurcio Francisco,Guerra Júnior Augusto A.,Araújo Vania E.,Diniz Leonardo M.,Godman BrianORCID,Almeida Alessandra M.,Alvares Juliana

Funder

Grupo de Pesquisa em Farmacoepidemiologia

National Council for Scientific Development and Technological (CNPq)

Publisher

Springer Science and Business Media LLC

Reference45 articles.

1. De Oliveira GL, Guerra Junior AA, Godman B, Acurcio FA. Cost-effectiveness of vildagliptin for people with type 2 diabetes mellitus in Brazil; findings and implications. Expert Rev Pharmacoecon Outcomes Res. 2017;17(2):109–19.

2. American Diabetes Association (ADA). Standards of medical care in diabetes. Position statement. Diabetes Care. 2017;40(1):S1–135.

3. German Institute for Quality and Efficency in Healthcare (IQWiG). Long-acting insulin analogues in the treatment of diabetes mellitus type 1: Executive Summary Commission No. A05-01. 2010. https://www.iqwig.de/en/projects_results/projects/drug_assessment/a05_01_long_acting_insulin_analogues_in_the_treatment_of_diabetes_mellitus_type_1.1197.html. Accessed 2 July 2017.

4. Souza ALC, de Acurcio AF, Junior AAG, do Nascimento RCRM, Godman B, Diniz LM. Insulin glargine in a Brazilian state: should the government disinvest? An assessment based on a systematic review. Appl Health Econ Health Policy. 2014;12(1):19–32.

5. WHO. World Health Organisation. Review of the Evidence Comparing Insulin (Human or Animal) With Analogue Insulins. 18th Expert Committee on the Selection and Use of Essential Medicines. 1–51. 2011. http://www.who.int/selection_medicines/committees/expert/18/applications/Insulin_review.pdf. Accessed 6 June 2017.

Cited by 37 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3